2026 ADA Guidelines Standards of Care in Diabetes: Pharmacological Management of Type 2 Diabetes Mellitus
VIOLET Study Summary: Real World Evaluation of Vildagliptin and Vildagliptin + Metformin in Type 2 Diabetes Patients (DRC 2025)
Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop.
